Related Experiment Video
Updated: Jan 27, 2026

Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression
Published on: February 3, 2023
Programmed Cell Death Ligand 1 Immunohistochemistry: A Concordance Study Between Surgical Specimen, Biopsy, and
Hedvig Elfving1, Johanna Sofia Margareta Mattsson1, Cecilia Lindskog1
1Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
Programmed cell death ligand 1 (PD-L1) expression analysis on non-small-cell lung cancer biopsies shows moderate agreement with resection specimens. This suggests potential misclassification, particularly at lower thresholds, impacting treatment decisions.
Area of Science:
- Oncology
- Immunohistochemistry
- Cancer Diagnostics
Background:
- Programmed cell death ligand 1 (PD-L1) expression analysis is crucial for diagnosing non-small-cell lung cancer (NSCLC).
- Current diagnostic workup often relies on small biopsy samples, which may not fully represent the entire tumor.
- Evaluating PD-L1 expression in biopsies against resection specimens is essential for diagnostic accuracy.
Purpose of the Study:
- To assess the correlation between PD-L1 expression in non-small-cell lung cancer (NSCLC) biopsy specimens and their corresponding resection specimens.
- To determine the reliability of using small biopsy samples for PD-L1 analysis in NSCLC.
Main Methods:
- Compared PD-L1 expression using immunohistochemistry (SP263 antibody) on biopsy samples, whole-section resection specimens, and tissue microarrays (TMAs).
- Analyzed 58 NSCLC cases with both preoperative biopsy and resection specimens.
- Evaluated concordance using 1% and 50% PD-L1 expression cutoffs.
Main Results:
- PD-L1 expression proportions were comparable across biopsies, TMAs, and resection specimens (e.g., 43% vs. 48% at 1% cutoff).
- Biopsy analysis demonstrated good sensitivity (79%-82%) and specificity (90%-98%) compared to resection specimens.
- Moderate agreement (Cohen's κ 0.70-0.83) was observed, with higher concordance at the 50% cutoff.
Conclusions:
- A moderate concordance exists between PD-L1 analysis on NSCLC biopsies and resection specimens.
- Potential for sample misclassification, especially at the lower 1% PD-L1 expression cutoff, requires clinical awareness.
- Clinicians must consider this uncertainty when interpreting PD-L1 results for NSCLC treatment decisions.
Related Concept Videos
Kendall's Coefficient of Concordance
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Ligand Binding and Linkage
Metal-Ligand Bonds
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...

